448 related articles for article (PubMed ID: 27586169)
21. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
[TBL] [Abstract][Full Text] [Related]
22. Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
Galve E; Oristrell G; Acosta G; Ribera-Solé A; Moya-Mitjans À; Ferreira-González I; Pérez-Rodon J; García-Dorado D
Clin Cardiol; 2018 Jun; 41(6):803-808. PubMed ID: 29604094
[TBL] [Abstract][Full Text] [Related]
23. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
Barsheshet A; Wang PJ; Moss AJ; Solomon SD; Al-Ahmad A; McNitt S; Foster E; Huang DT; Klein HU; Zareba W; Eldar M; Goldenberg I
J Am Coll Cardiol; 2011 Jun; 57(24):2416-23. PubMed ID: 21658562
[TBL] [Abstract][Full Text] [Related]
24. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
[TBL] [Abstract][Full Text] [Related]
25. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
Goldenberg I; Moss AJ; Hall WJ; Foster E; Goldberger JJ; Santucci P; Shinn T; Solomon S; Steinberg JS; Wilber D; Barsheshet A; McNitt S; Zareba W; Klein H;
Circulation; 2011 Oct; 124(14):1527-36. PubMed ID: 21900084
[TBL] [Abstract][Full Text] [Related]
26. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
[TBL] [Abstract][Full Text] [Related]
27. Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.
Kronborg MB; Johansen JB; Haarbo J; Riahi S; Philbert BT; Jørgensen OD; Nielsen JC
Europace; 2018 Sep; 20(9):e133-e139. PubMed ID: 29036292
[TBL] [Abstract][Full Text] [Related]
28. Cardiac Resynchronization Therapy in CKD Stage 4 Patients.
Höke U; Khidir MJ; van der Velde ET; Schalij MJ; Bax JJ; Delgado V; Marsan NA
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1740-8. PubMed ID: 26408549
[TBL] [Abstract][Full Text] [Related]
29. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience.
Frigerio M; Lunati M; Pasqualucci D; Vargiu S; Foti G; Pedretti S; Vittori C; Cattafi G; Magenta G; Campo C; Bisetti S; Mercuro G
Int J Cardiol; 2014 Mar; 172(1):64-71. PubMed ID: 24456869
[TBL] [Abstract][Full Text] [Related]
31. Combined baseline strain dyssynchrony index and its acute reduction predicts mid-term left ventricular reverse remodeling and long-term outcome after cardiac resynchronization therapy.
Tatsumi K; Tanaka H; Matsumoto K; Miyoshi T; Hiraishi M; Tsuji T; Kaneko A; Ryo K; Fukuda Y; Norisada K; Onishi T; Yoshida A; Kawai H; Hirata K
Echocardiography; 2014 Apr; 31(4):464-73. PubMed ID: 24138588
[TBL] [Abstract][Full Text] [Related]
32. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Kutyifa V; Kloppe A; Zareba W; Solomon SD; McNitt S; Polonsky S; Barsheshet A; Merkely B; Lemke B; Nagy VK; Moss AJ; Goldenberg I
J Am Coll Cardiol; 2013 Mar; 61(9):936-44. PubMed ID: 23449428
[TBL] [Abstract][Full Text] [Related]
33. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
34. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
[TBL] [Abstract][Full Text] [Related]
35. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
Kim M; Kim J; Lee JH; Hwang YM; Kim MS; Nam GB; Choi KJ; Kim JJ; Kim YH
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1191-1198. PubMed ID: 27334231
[TBL] [Abstract][Full Text] [Related]
36. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
[TBL] [Abstract][Full Text] [Related]
37. Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.
Zeitler EP; Friedman DJ; Daubert JP; Al-Khatib SM; Solomon SD; Biton Y; McNitt S; Zareba W; Moss AJ; Kutyifa V
J Am Coll Cardiol; 2017 May; 69(19):2369-2379. PubMed ID: 28494974
[TBL] [Abstract][Full Text] [Related]
38. "Real world" experience in Cardiac Resynchronization Therapy at a Swiss Tertiary Care Center.
Winnik S; Elsener C; Seifert B; Starck C; Straub A; Saguner AM; Breitenstein A; Krasniqi N; Wilhelm MJ; Haegeli L; Duru F; Benussi S; Maisano F; Lüscher TF; Holzmeister J; Huerlimann D; Ruschitzka F; Steffel J
Swiss Med Wkly; 2017; 147():w14425. PubMed ID: 28421570
[TBL] [Abstract][Full Text] [Related]
39. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
[TBL] [Abstract][Full Text] [Related]
40. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
